Neuroprotection against neonatal hypoxia/ischemia-induced cerebral cell death by prevention of calpain-mediated mGluR1α truncation

Medicine & Life Sciences

• metabotropic glutamate receptor type 1 100%
• Brain Hypoxia-Ischemia 89%
• Calpain 85%
• Neuroprotection 72%
• Cell Death 52%
• Hypoxia 36%
• Ischemia 34%
• Excitatory Amino Acid Antagonists 19%
• Peptides 19%
• calpain inhibitors 11%
• Oxygen 10%
• Human Immunodeficiency Virus Proteins 10%
• Spectrin 10%
• Glucose 9%
• aspartic acid receptor 9%
• Glutamate Receptors 8%
• Protein Domains 7%
• Animal Models 5%
• Clinical Trials 5%
• In Vitro Techniques 3%